Home
Glaxosmithkline Pharmaceuticals Ltd EPS

Glaxosmithkline Pharmaceuticals Ltd
NSE: GLAXO
EPS
Key Highlights
- The Earning per Share of Glaxosmithkline Pharmaceuticals Ltd is ₹ 50.42 as of 21 Feb 25 .
- The earning per share of Glaxosmithkline Pharmaceuticals Ltd changed from ₹ 7.04 to ₹ 13.57 over 7 quarters. This represents a CAGR of 45.50% .
Historical Earning per Share of Glaxosmithkline Pharmaceuticals Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
Historical Earning per Share of Glaxosmithkline Pharmaceuticals Ltd
Company Fundamentals for Glaxosmithkline Pharmaceuticals Ltd
Market Cap
42,500 Cr
EPS
50.4
P/E Ratio (TTM)
49.8
P/B Ratio (TTM)
25.4
Day’s High
2586.0
Day’s Low
2487.55
DTE
0.0
ROE
47.9
52 Week High
3087.95
52 Week Low
1825.05
ROCE
64.4
Market Price of Glaxosmithkline Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 2508.8 |
20 Feb 2025 | 2569.45 |
19 Feb 2025 | 2510.2 |
18 Feb 2025 | 2529.7 |
17 Feb 2025 | 2332.25 |
14 Feb 2025 | 2017.75 |
13 Feb 2025 | 1995.65 |
12 Feb 2025 | 2031.5 |
11 Feb 2025 | 2056.25 |
10 Feb 2025 | 2141.55 |
SWOT Analysis Of Glaxosmithkline Pharmaceuticals Ltd
BlinkX Score for Glaxosmithkline Pharmaceuticals Ltd
Asset Value vs Market Value of Glaxosmithkline Pharmaceuticals Ltd
Market Value
₹ 42,501
Asset Value
Value addition
18.8 X
₹ 2,149
* All values are in ₹ crores
Competitive Comparison of EPS
Company | Market Cap | EPS |
---|
Glaxosmithkline Pharmaceuticals Ltd | 42500 | 50.42 |
Sun Pharmaceuticals Industries Ltd | 394223 | 49.16 |
Divis Laboratories Ltd | 152610 | 77.86 |
Cipla Ltd | 119067 | 61.78 |
Torrent Pharmaceuticals Ltd | 102739 | 55.02 |
Dr Reddys Laboratories Ltd | 96124 | 64.37 |
Company | |
---|---|
Glaxosmithkline Pharmaceuticals Ltd | 42500 |
Sun Pharmaceuticals Industries Ltd | 394223 |
Divis Laboratories Ltd | 152610 |
Cipla Ltd | 119067 |
Torrent Pharmaceuticals Ltd | 102739 |
Dr Reddys Laboratories Ltd | 96124 |
Historical Market Cap of Glaxosmithkline Pharmaceuticals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Glaxosmithkline Pharmaceuticals Ltd
Historical Revenue of Glaxosmithkline Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Glaxosmithkline Pharmaceuticals Ltd
Historical EBITDA of Glaxosmithkline Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Glaxosmithkline Pharmaceuticals Ltd
Historical Net Profit of Glaxosmithkline Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Glaxosmithkline Pharmaceuticals Ltd
Dividend Payout Over Time
Glaxosmithkline Pharmaceuticals Ltd News Hub
Glaxosmithkline Pharmaceuticals consolidated net profit rises 37.87% in the June 2024 quarter
Net profit of Glaxosmithkline Pharmaceuticals rose 37.87% to Rs 182.33 crore in the quarter ended Ju
Read more
05 Aug 24
GSK Pharma Q1 PAT climbs 39% YoY to Rs 182 crore
Revenue from operations grew by 9.89% year on year (YoY) to Rs 811 crore during the quarter ended Ju
Read more
03 Aug 24
GlaxoSmithKline Pharmaceuticals to declare Quarterly Result
GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 29 O
Read more
25 Oct 24
Board of GlaxoSmithKline Pharmaceuticals recommends Special Interim Dividend
GlaxoSmithKline Pharmaceuticals announced that the Board of Directors of the Company at its meeting
Read more
29 Oct 24
Document
Concalls